Menu

An expert resource for medical professionals
Provided FREE as a service to women’s health

The Alliance for
Global Women’s Medicine
A worldwide fellowship of health professionals working together to
promote, advocate for and enhance the Welfare of Women everywhere

An Educational Platform for FIGO

The Global Library of Women’s Medicine
Clinical guidance and resources

A vast range of expert online resources. A FREE and entirely CHARITABLE site to support women’s healthcare professionals

The Global Academy of Women’s Medicine
Teaching, research and Diplomates Association

This chapter should be cited as follows:
Kjaer ASL, Pinborg A, et al, Glob. libr. women's med.,
ISSN: 1756-2228; DOI 10.3843/GLOWM.421173

The Continuous Textbook of Women’s Medicine SeriesGynecology Module

Volume 15

Reproductive medicine for the obstetrician and gynecologist

Volume Editors: Professor Luca Gianaroli, S.I.S.Me.R. Reproductive Medicine Institute, Italy; Director of Global Educational Programs, IFFS
Professor Edgar Mocanu, RCSI Associate Professor in Reproductive Medicine and Surgery, Rotunda Hospital, Ireland; President, IFFS
Professor Linda Giudice, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, USA; Immediate Past President, IFFS

Published in association with the
International Federation of
Fertility Societies

Chapter

Short- and Long-term Health in Children Born after ART

First published: November 2024

Study Assessment Option

By completing 4 multiple-choice questions (randomly selected) after studying this chapter readers can qualify for Continuing Professional Development awards from FIGO plus a Study Completion Certificate from GLOWM
See end of chapter for details

INTRODUCTION

Worldwide more than 10 million children have been born after assisted reproductive technology (ART) fulfilling the family formation wishes for couples facing infertility and also their desire of having healthy children. Therefore, continuous surveillance of the short- and long-term health outcomes of ART procedures compared with natural conception (NC), is essential for informed decision-making in clinical practice for the future parents and clinicians working in the field.

This chapter explores the current literature on short- and long-term health outcomes of ART versus NC and the nuances of different ART procedures, including intracytoplasmic sperm injection (ICSI) versus in vitro fertilization (IVF), frozen embryo transfer (FET) versus fresh embryo transfer, blastocyst versus cleavage stage embryo transfer, and oocyte donation. Furthermore, the possible causes for altered short- and long-term outcomes in children born after ART is discussed (Figure 1).

1

Factors affecting obstetric and perinatal outcomes and potentially short- and long-term health of offspring conceived by assisted reproductive technology (ART). Created with BioRender.com.

SHORT-TERM HEALTH OUTCOMES FOLLOWING ASSISTED REPRODUCTIVE TECHNOLOGY

Assisted Reproductive Technology versus Natural Conception

Multiple Births

Multiple births are still a major concern in ART, due to the substantial elevated risks of adverse obstetric and perinatal outcomes with a greater risk of short- and long-term morbidity in the children such as neurodevelopmental diseases.1,2,3,4,5,6,7 Based on the Committee of Nordic ART and Safety (CoNARTaS), a recent multinational cohort study yielded that the risk of cerebral palsy (CP) among ART children was significantly reduced from the early 1990s to 2015 due to a lower risk of preterm birth (PTB) caused by the reduction in multiple births.8

In Europe, the twin birth rate after ART decreased from 28% to 15% between 1997 and 2016.10,12 A similar trend occurred in the United States, where the twin birth rate dropped from 27% to 10% between 2000 and 2018.11 In the Nordic countries, increased adoption of single embryo transfers resulted in a decrease in twin birth rates within the ART population, dropping from nearly 30% in 1994 to 4–13% in 2014 and now below 5% in all Nordic countries.14,15

Based on data from the CoNARTaS cohort, it is evident that rates of placenta-mediated complications, PTB, low birth weight (LBW), and stillbirth have substantially decreased in the Nordic countries in parallel with the declining twin birth rates.16 However, despite the high survival rates of frozen/thawed embryos and the risks associated with twin pregnancies, double embryo transfer remains the standard procedure in many countries, even for couples with a favorable prognosis for achieving pregnancy and live birth.11,12,13,17 Hence, there is still a crucial need to ensure the well-being of children born through ART by the widespread implementation of the "single embryo transfer" policy.9,18

Singletons

Extensive cohort studies consistently reveal that even singleton pregnancies resulting from ART carry a slightly elevated risk of adverse outcomes compared with NC singletons.

In a recent systematic review and meta-analysis encompassing 52 cohort studies worldwide, data from over 180,000 singleton pregnancies after fresh and FET were analyzed.19 The analysis unveiled significant disparities in perinatal outcomes between ART and NC. The absolute differences in the prevalence of adverse perinatal outcomes between singletons born after ART and NC were 4.5% for PTB, 1.2% for very preterm birth (VPTB), 2.9% for LBW, 1.0% for very LBW (VLBW), 1.4% for small-for-gestational-age (SGA), 0.4% for perinatal mortality and 1.8% for congenital malformations; all values were statistically significant with P-values <0.001.19 Recently, a meta-analysis involving 19 cohort studies and 68,000 ART singleton pregnancies yielded an increased risk of stillbirth after ART, with a pooled risk of odds ratio (OR) 1.41 (95% CI 1.20–1.65) and the crude stillbirth rate being 4.44/1000 total births.20 Another meta-analysis, comprising 22 cohort studies in singletons, reported an elevated relative risk (RR) of congenital malformations (RR 1.41, 95% CI 1.30–1.52) in ART versus NC singletons, but most studies included in their analysis focused on older birth cohorts, and none included data on birth cohorts born after 2010.21

Based on CoNARTaS data including more than 90,000 ART children born in the Nordic countries, the absolute prevalence of congenital malformations was 3.4% versus 2.9% in NC children and the RR of a congenital malformation remained similar over a four-decade period from 1988 to 2007.22 The adjusted risk for ART versus NC singletons in the Nordic countries over the full period being adjusted OR (aOR) 1.14 (95% CI 1.08–1.20).

Intracytoplasmic Sperm Injection versus In Vitro Fertilization

The comparison of outcomes following ICSI and IVF pregnancies is a topic of considerable interest. Most large cohort studies generally indicate similar or even lower risks of PTB, LBW, and perinatal mortality in singletons born after ICSI compared to IVF.22,23 A meta-analysis based on five cohort studies showed a lower risk of PTB in ICSI versus IVF pregnancies (both fresh and FET) with an aOR of 0.80 (95% CI 0.69–0.93).23 The cause of better perinatal outcomes after ICSI is most probably the effect of healthier mothers with no reproductive diseases. This is supported by a large cohort study based on the national HFEA data in the UK, where female causes of infertility were associated with a higher risk of PTB and LBW in singletons born after IVF/ICSI.24 Whether the risk of congenital malformations differs between ICSI and IVF offspring remains the subject of ongoing debate.25,26,27,28 A systematic review and meta-analysis on 19 studies found no increased risk of chromosome abnormalities in the adjusted data when comparing ICSI to either standard IVF (aOR 0.75, 95% CI 0.41–1.38) or NC (aOR 1.29, 95% CI 0.69–2.43).26 In contrast, a recent register-based Nordic study by the CoNARTS group in 86,862 live-born singletons showed a slight but significantly higher risk of major congenital malformations, especially contributed to respiratory and chromosomal malformations, among fresh ICSI compared to fresh IVF (aOR 1.07, 95% CI 1.01–1.14). They found no difference when comparing ICSI used for male infertility factor and ICSI for other indications, except for the risk of hypospadias where the risk was significantly higher when male factor infertility was present.25 These results indicate that hypospadias in the offspring may be related to intrinsic paternal factors and not the ART per se, while for the other malformations it seems that there is no relation to the low semen quality but rather the ICSI procedure.

Frozen Embryo Transfer versus Fresh Embryo Transfer

Initial systematic reviews and meta-analyses yielded promising results for FET pregnancies with a reduced risk of PTB, LBW, and SGA in FET offspring, while the risks of stillbirth and perinatal deaths were comparable to those after fresh cycles.23,29,30,31 However, a Finnish cohort study in 2010, involving 2293 FET children, revealed a higher risk of large-for-gestational age (LGA) in FET children.32 A recent systematic review and meta-analysis encompassing 26 studies offered a more comprehensive understanding of FET outcomes, where pooled risk estimates confirmed a lower relative risk of PTB, LBW, and SGA in pregnancies following FET compared to fresh cycles.33 Conversely, the risk of LGA offspring and a birth weight exceeding 4500 g as well as hypertensive disorders of pregnancy (HDP) was increased in FET pregnancies. In accordance, a recent Cochrane review on elective FET versus fresh embryo transfer found an increased risk of HDP (OR 2.15, 95% CI 1.42–3.25), LGA offspring (OR 1.96, 95% CI 1.51–2.55) and a higher birth weight (mean difference 127.4 g, 95% CI 77.1–177.8) of children born following the 'freeze all' strategy.34 Additionally, convincing data have shown that programmed-FET cycles with endometrial preparation with sequential estradiol and progesterone without the creation of a corpus luteum in comparison with natural cycle FET (NC-FET) contribute to a higher risk of HDP, postpartum hemorrhage (PPH) and overgrowth in FET singletons.35,36,37 In agreement, a recent systematic review showed significantly decreased risk of HDP (aOR 0.52, 95% CI 0.47–0.52), pre-eclampsia (PE) (aOR 0.43, 95% CI 0.37–0.51), LGA (aOR 0.87, 95% CI 0.80–0.93) and PPH (0.44, 95% CI 0.36–0.47) in the NC-FET group compared to programmed-FET.38 In ART pregnancies the absence of a corpus luteum leads to undetectable levels of relaxin, which is a potent vasodilator. This may be a plausible explanation for the adverse outcomes observed in pregnancies without a corpus luteum.39,40,41

Blastocyst versus Cleavage Stage Transfer

The practice of extending the culture time of embryos to the blastocyst stage before transfer in ART has sparked considerable scientific interest. This extended exposure of the in vitro cultured blastocyst to external stressors for 2–3 additional days, compared to cleavage stage embryos, has raised questions about its effects on embryo implantation, placentation, and early fetal development. The in vitro environment differs significantly from the uterine environment in terms of temperature, pH, oxygen concentration, and the mechanical processes involved, including pipetting. Moreover, the extended culture time means embryo development in vitro beyond the time of embryonic genome activation (occurring on day three after fertilization), making blastocysts potentially more sensitive to epigenetic changes. Finally, the culture media used for blastocyst embryos differs from that used for cleavage stage embryos.42 Emerging evidence suggests that the culture medium itself may influence specific gene expressions, perinatal outcomes, and the rate of monozygotic twinning (MZT);43,44,45,46 however, not all studies on this subject find that the culture media plays an important role in offspring phenotype.47 Additionally, the prolonged culture time reduces the window for communication between the embryo and endometrium before implantation, potentially compromising synchronization.

Despite these concerns, extended culture time has its advantages. It facilitates a more stringent selection of viable embryos, potentially leading to healthier pregnancies. In fresh cycles, waiting until day 5 or 6 for embryo transfer leads to an extended duration from ovarian stimulation and more normalized hormone levels. This results in an endometrial environment that more closely resembles that of a natural cycle.

A comprehensive meta-analysis by Marconi et al. from 2021 reviewed perinatal outcomes in children born after blastocyst and cleavage stage transfer, fresh and frozen.48 The analysis included 35 cohort studies or randomized controlled trials with a total of 520,769 singleton pregnancies. When considering fresh blastocyst transfer, it was observed that singleton pregnancies exhibited a heightened risk of LGA with a RR of 1.14 (95% CI 1.05–1.24). Additionally, there was a higher risk of VPTB with an RR of 1.17 (95% CI 1.08–1.26) when compared to fresh cleavage stage transfer. Moreover, singleton pregnancies following frozen blastocyst transfer also displayed distinct trends. These pregnancies were associated with elevated risks of LGA (RR 1.17, 95% CI 1.08–1.27) and PTB (RR 1.13, 95% CI 1.03–1.24). However, they exhibited lower risks of being SGA (RR 0.84, 95% CI 0.74–0.95), as well as a reduced risk of perinatal mortality (RR 0.70, 95% CI 0.58–0.86). The increased risks of PTB following fresh blastocyst transfer and increased risk of LGA and PTB following frozen blastocyst transfer remained consistent in sensitivity analysis including adjustments for effect sizes of the included studies. A recent large cohort study from 2023 including 1290 sibling pairs was able to perform a sibship comparison on blastocyst and cleavage stage offspring. They confirmed the increased risk of LGA in fresh cycles after blastocyst transfer (RR 1.57, 95% CI 1.01–2.46).49

Another meta-analysis from 2023 found no increased risk of congenital malformations after blastocyst transfer compared to cleavage stage transfer when including results from 10 studies and 192,442 liveborn neonates.50 They did find a slightly higher probability of a male neonate with a RR of 1.072 (95% CI 1.055–1.088) based on 18 studies and 227,530 neonates. Some have hypothesized that a potentially accelerated growth of male embryos could contribute to the overrepresentation of male blastocysts and, consequently, a higher male-to-female ratio among offspring. One study supported this notion by demonstrating that male blastocysts achieved a higher embryo morphological score compared to female embryos.51 Another study proposed that abnormal X-chromosome inactivation might result in postimplantation fetal loss, thereby skewing the male-to-female ratio.52

The association between blastocyst transfer and the risk of monozygotic twinning (MZT) has garnered considerable attention. A meta-analysis by Hviid et al. in 2018, incorporating 11 original articles and 88,565 pregnancies after blastocyst transfer, revealed a two-fold increased risk of MZT.46 This risk is of particular concern due to the potential complications associated with multiple pregnancies and the development of twin-to-twin transfusion syndrome. Studies have suggested that the culture medium itself may contribute to the higher rate of MZT after blastocyst transfer, with glucose levels in the medium being a suspected factor. Elevated glucose levels in blastocyst media may lead to increased free radicals, apoptosis, and disruptions in the inner cell mass, potentially causing embryo splitting.46

Oocyte Donation

The risk of several obstetric and perinatal adverse outcomes is increased in pregnancies with oocyte donation (OD) compared to ART with autologous oocytes and NC pregnancies. A recent systematic review and meta-analysis showed a pooled adjusted OR for PE of 2.67 (95% CI 2.28–3.13) in OD compared with ART with autologous oocytes.53 The pooled prevalence of PE in singleton pregnancies after OD was 10.7% (95% CI 6.6–15.5) compared to 2.0% (95% CI 1.0–3.1) after NC and 4.1% (95% CI 2.7–5.6) after ART with autologous oocytes. The prevalence of PE in multiple births was 27.8% (95% CI 23.6–32.2) after OD, 7.5% (95% CI 7.2–7.8) after NC, and 9.7% (95% CI 6.2–13.9) after ART with autologous oocytes. Potential contributors to the increased risk of PE on pregnancies after OD are advanced maternal age, an amplified immunological response due to the genetically different fetus and the lack of a corpus luteum as most OD treatments are performed in programmed-FET cycles, as ovarian insufficiency in the patients makes induced ovulation impossible. Further, pregnancies with OD carry an increased risk of first-trimester bleeding, gestational diabetes and PPH.54

Finally, some perinatal outcomes are less favorable after OD compared to ART with autologous oocytes such as PTB (OR 1.57, 95% CI 1.33–1.86) and LBW (OR 1.25, 95% CI 1.20–1.30), but in adjusted analysis they seem to be somewhat driven by the higher PE incidence.55,56

As a precaution, it is therefore highly encouraged to perform only single embryo transfer and to prescribe prophylactic low-dose aspirin during pregnancies after OD to lower the risk of PE. Further, whenever possible OD should be performed in natural or stimulated FET cycles instead of programmed.

LONG-TERM HEALTH OUTCOMES IN OFFSPRING FOLLOWING ASSISTED REPRODUCTIVE TECHNOLOGY

The long-term implications for children being born through ART have been examined to varying extents, depending on the specific health outcomes. Studies focusing on the enduring health consequences in the offspring of different types of ART treatments are limited.

Neurodevelopmental Health

Cognitive Development

Since the inception of ART in the late 1970s, concerns have arisen regarding the cognitive development of ART children. These concerns primarily stem from the advanced techniques and the impaired perinatal outcomes that could affect fetal brain development.57,58 Numerous studies have explored different aspects of cognitive development in ART children, particularly in pre-schoolers up to 5 years of age. Overall, these studies conclude that there is no difference in IQ, language development, or scholastic abilities.59 Studies examining cognitive development in ART children have been incorporated into two systematic reviews and one meta-analysis.60,61,62 The overarching conclusion drawn from these three meta studies is largely reassuring. Nevertheless, many of the existing studies are hampered by methodological limitations, such as low participation rates and small sample sizes with a high risk of selection bias. Additionally, the control cohorts in the studies often consist of highly selected individuals from generally healthy populations.

In recent years, larger cohort studies focusing on academic performance in ART children have emerged, contributing additional insights into ART children’s cognitive development. The first comprehensive study on school performance encompassed all ART singletons (n = 2836) born in Denmark between 1995 and 1998, evaluating mean school grades after 9 years of primary school.63 The main outcome measure was the mean total score of four subjects. ART singletons were found to have a higher crude mean total score but a slightly lower adjusted mean total score of −0.15 (95% CI −0.29 to −0.02) compared to NC singletons. The authors concluded that a possible small negative effect of parental subfertility or ART treatment is counterbalanced by the higher educational level of the ART parents. The findings were replicated in a Swedish cohort study comprising 8323 singleton individuals conceived through ART between the years 1985 and 2001 in Sweden.64 The unadjusted mean total score in ART-conceived children was higher than that in NC children, but the mean total score, after adjusting for confounding variables, exhibited a slight decrease of −0.72 (95% CI −1.31 to −0.12).64

Subsequently, in 2020 a Danish cohort study, overlapping with the study from Spangmose et al. but including two more birth years, included new comparison groups: (1) an infertile cohort of firstborn ART adolescents, (2) a fertile cohort of firstborn NC adolescents born to mothers who never sought fertility treatment, and (3) a subfertile cohort of firstborn NC adolescents born to mothers who sought fertility treatment in their second pregnancy.65 The inclusion of the subfertile cohort aimed to disentangle maternal factors from treatment-related factors. This study confirmed the findings and those of the first Danish study and the Swedish study:63,64 crude mean test scores were higher in ART adolescents, but they were lower after adjustments for maternal/parental educational level and socioeconomic status. Interestingly, the adjusted analyses showed a lower mean test score in NC adolescents in the subfertile cohort than in NC adolescents in the fertile cohort, with an adjusted mean difference of −0.19 (95% CI −0.26 to −0.13). Furthermore, the mean test score was similar in ART adolescents and NC adolescents in the subfertile cohort. These results suggest that the underlying infertility (reproductive disease) rather than the ART procedures per se influences academic performance.65

Owing to the invasiveness of the ICSI procedure and the randomized selection of spermatozoa, numerous studies have probed into the cognitive outcomes of children born as a result of ICSI. Two large cohort studies compared academic performance in ICSI and IVF adolescents and no differences were found.63,66 In one cohort study, FET adolescents were found to exhibit academic performance similar to that of adolescents born following fresh embryo transfer.67

Psychiatric Health

The risk of psychiatric disease in children and adolescents has primarily been investigated in Danish and Swedish cohorts. In three large Danish cohort studies and one Nordic study that included children up to their teenage years, no increased risk of mental retardation, autism, or Asperger's syndrome was found in children born after ART, whether singletons or twins.68,69,70,71 A similar risk of autism in ART and NC children has been confirmed in a large cohort study from Massachusetts, including 10,147 ART children and 8072 children of subfertile parents.72 Likewise, a meta-analysis found no increased risk of intellectual disabilities or autism in ART children based on 5 (n = 45,263 ART children) and 6 studies (n = 59,075 ART children), respectively.61

One Danish study investigated mental disorders in 108,707 singletons of women with fertility problems born from 1969 to 2006.73 These singletons exhibited an elevated risk for various mental health conditions, including schizophrenia (hazard ratio [HR] 1.16, 95% CI 1.06–1.27), mood (affective) disorders (HR 1.22, 95% CI 1.15–1.29), autism (HR 1.11, 95% CI 1.03–1.19), mental retardation (HR 1.19, 95% CI 1.08–1.32) as well as ADHD (HR 1.36, 95% CI 1.29–1.45) compared with singletons born to women without fertility problems. The risk estimates remained relatively consistent when the analysis was stratified into two age categories: mental disorders diagnosed during childhood (0–19 years) and those emerging in young adulthood (20–40 years). However, it is worth noting that no adjustments were made for socioeconomic status.73 The elevated risk of ADHD in children born through ART compared with NC children has been substantiated by a recent 2022 Canadian study (adjusted HR [aHR] 1.17, 95% CI 1.07–1.28). Interestingly, also offspring born to infertile parents without fertility treatment had an increased risk of ADHD (aHR 1.12, 95% CI 1.16–1.23) compared with NC children.74 This suggests a modest association between infertility and the risk of childhood ADHD, rather than a direct link to the use of fertility treatment itself. The study was able to consider critical factors associated with ADHD, including socioeconomic parameters.74 A large Swedish study from 2011 including birth years 1982–2005 (ART children, n = 28,158)75 and a large Nordic study from 2022 including singletons born in 1995–2014 in Denmark and Finland, 2005–2015 in Norway, and 1995–2015 in Sweden (ART children, n = 116,909)71 found a similar risk of ADHD in ART and NC singletons. Note that the Swedish cohort overlap in the two studies.71,75

Cerebral Palsy

CP stands as the most prevalent motor disability in childhood, affecting a significant portion of the general child population, with an estimated prevalence ranging from 1.5 to 3.5 per 1000 live births,76 the risk of CP increases significantly with the number of fetuses in a pregnancy, primarily due to the heightened risk of premature birth, which is the most prominent risk factor for CP.1,3

Several cohort studies have revealed an approximately two-fold increased risk of CP in the overall ART population.3,27,77,78,79,80,81 While other studies show no elevated risk of CP among ART singletons.8,78,79,80,82,83 According to the CoNARTaS data, it was observed that the risk of CP decreased over time among children born through ART due to a reduction in the rate of multiple births.8 In the years 1990–1993, ART children had a significantly higher aOR for CP (aOR 2.76, 95% CI 2.03–3.67) compared to NC children. By 2011–2014, the risk had diminished and was only moderately increased (aOR 1.39, 95% CI 1.01–1.87). For singleton births during the period 2011–2014, the risk was no longer elevated (aOR 1.11, 95% CI 0.98–1.24).

In general, the literature on neurodevelopmental health in singletons born after ART is reassuring, but multiple pregnancies should be diminished to avoid the risks associated with PTB.

Cardiometabolic Health

Cardiovascular Health

ART children have been examined for cardiovascular health, including, elevated blood pressure84,85,86 and suboptimal cardiac diastolic function.87,88 However, many of these studies, summarized in systematic reviews, are based on small cohorts with low participation rates, resulting in a high risk of selection bias.89,90 Guo et al. scrutinized the cardiovascular health of ART children, spanning from childhood to early adulthood.90 Among 872 ART children, the study exhibited higher systolic and diastolic blood pressure with mean differences of 1.88 mmHg (95% CI 0.27–3.49) and 1.51 mmHg (95% CI 0.33–2.70), respectively, compared with NC children. However, stratification by birth year revealed that only ART children born between 1990 and 1999, but not from 2000 to 2009, displayed increased systolic and diastolic blood pressure. The included studies consistently showed suboptimal diastolic function in ART children, especially under stressful conditions like high altitudes. Furthermore, the thickness of the aortic and carotid intima-media was notably higher in the ART group, although a meta-analysis on this was not conducted due to a limited number of studies.90 It should be emphasized that most of the studies in this area are small and carry a high risk of selection bias. Recent cohort studies, although still featuring small study populations, have not shown notable differences in cardiovascular profiles between ART and NC adolescents.91,92,93 A few large studies have explored the association between ART and cardiovascular diseases. In a population-based cohort study encompassing individuals born in Denmark, Finland, Norway, and Sweden between 1984 and 2015, data from national ART and medical birth registers were cross-referenced with national patient registers and other population-based registers.94 The study included 122,429 children born after ART. Of these, 135 (0.11%) children born after ART were diagnosed with various cardiovascular diseases (ischemic heart disease, cardiomyopathy, heart failure, or cerebrovascular disease). After adjustments, similar risks were observed for children born after ART and NC for any cardiovascular disease (aHR 1.02, 95% CI 0.86–1.22). Notably, the study's limitations included the relatively short follow-up period, 8.6 and 14.0 years for children born after ART and NC, respectively, and few events for some outcomes. Therefore, while the results were generally reassuring, continued monitoring and surveillance for these important diseases are crucial.

In summary, limited data suggest potentially elevated blood pressure in ART children. However, large register-based studies have not confirmed significant heightened risks for cardiovascular disease in ART children thus far.

Type 1 Diabetes

Three cohort studies have been conducted on the risk of type 1 diabetes (DM1) in children born following ART, two in Denmark and one in Sweden. These studies collectively found no significant association between ART and the risk of developing DM1 later in life.95,96,97 However, in the Swedish study, they performed a subgroup analysis in children born after FET and found an increased risk of DM1 when compared to both children after fresh embryo transfer and NC children, with aHR values of 1.52 (95% CI 1.08–2.14) and 1.41 (95% CI 1.05–1.89), respectively.97

A possible explanation for the increased risk of DM1 found in children born after FET might be the higher birth weight and higher rate of LGA associated with FET more than the FET procedure per se, as birth weight and LGA are independently associated with the risk of obesity and metabolic disease later in life.98 A recent Nordic register-based study including 77,920 ART children and 4,511,667 non-ART-children found no increased risk of DM1 in the children born after ART – the results have at this point only been published in an abstract.99

Growth and Body Composition

Two systematic reviews with accompanying meta-analyses explored differences in height, weight, and body mass index (BMI) between ART and NC children.90,100 Their findings revealed a slight negative association between ART and childhood weight, although only apparent up to the age of five, and no significant association between ART and height or BMI.90,100 Similarly, a cohort study including data from 26 population-based studies with anthropometric measures at several timepoints across childhood and adolescence found that offspring conceived after ART were smaller and had lower adiposity during early life than those who were NC, while differences diminished with advanced child age. However, they found a non-significant trend towards higher adiposity by early adulthood with ART conception (difference in fat mass index 0.23 SD units, 95% CI −0.04 to 0.50).101

Another Nordic retrospective cohort study including 122,429 children born after ART compared to NC children observed a small but significant increased risk of childhood obesity among children born after ART (aHR 1.14, 95% CI 1.06–1.23).94 A recent Danish study compared anthropometric measures in children aged 7–10 years born after fresh embryo transfer, FET and NC. In a sex-stratified analysis, weight (presented as sex- and age-specific standard deviation scores (SDS) and height (SDS) were significantly higher in girls born after FET compared to NC while the fat percentage in girls born after FET was increased compared to fresh embryo transfer. No differences were seen for boys. Importantly, outcomes were adjusted for birth weight.102

Overall, the data on growth and body composition in children born after ART seems reassuring as the identified differences in risk of obesity are only modest and seem to diminish with advancing age.

Cancer

The question of whether ART elevates the risk of cancer remains a topic of debate. It is important to note that the heightened risk has predominantly been observed in specific subgroups of ART children and for particular types of cancer.17 Two comprehensive systematic reviews with corresponding meta-analyses, one encompassing 13 cohort studies and the other including 11 case-control studies and 16 cohort studies, failed to reveal an increased risk of childhood cancer in ART children.103,104 Though the largest meta-analysis did identify an elevated risk of childhood cancer in children born after FET when compared to NC children, based on findings from five studies involving 25,563 FET children yielding a RR of 1.37 (95% CI 1.04–1.81).103

One of the first studies to note a slightly increased risk of any malignancy in children from FET compared to NC was a Danish population-based registry study. However, this finding was based on few cases.105

More recently, a large Nordic registry-based cohort study, which included 171,774 children born after ART and 7,772,474 NC children, did not identify an overall elevated risk of childhood cancer in children born after ART.106 However, a higher risk was observed in children born after FET (48 cases; incidence rate 30.1/100,000 person-years) when compared to both fresh embryo transfer (incidence rate 18.8/100,000 person-years, aHR 1.59, 95% CI 1.15–2.20) and children born after NC (aHR 1.65, 95% CI 1.24–2.19).106 Leukemia was the most common type of cancer observed and was significantly increased both in children born after FET compared to fresh embryo transfer and in children born after FET compared to those born through NC. The exact mechanism behind the potentially increased risk in children born after FET is not clear. However, singletons born after FET are at a heightened risk of macrosomia, which itself has been associated with an increased risk of childhood cancer.107

In summary, most studies provide reassurance by demonstrating no increased risk of overall cancer in children born after ART. Nevertheless, a slightly elevated risk was observed in children born after FET. Although the actual number of childhood cancer cases was relatively low, the study raises concerns regarding the significant rise in FET procedures, especially in cases where there are no clear medical justifications for using the freeze-all approach.

Imprinting Disorders

Imprinting disorders are caused by disruptions in epigenetic regulation at specific imprinted genetic loci, affecting aspects of growth, development, and metabolism.108 The latest systematic review and meta-analysis focusing on imprinting disorders following ART unveiled that ART children exhibited an elevated risk of developing all four major imprinting disorder examined; Angelman (summary OR [sOR] 4.7, 95% CI 2.6–8.5, 4 studies), Beckwith-Wiedemann (sOR 5.8, 95% CI 3.1–11.1, 8 studies), Prader-Willi (sOR 2.2, 95% CI 1.6–3.0, 6 studies) and Silver-Russel Syndrome (sOR 11.3, 95% CI 4.5–28.5, 3 studies) compared with NC children.109 However, a more recent cohort study, not included in the initial meta-analysis, scrutinized a cohort of nearly 75,000 ART children born in Denmark and Finland and found no overall increased risk of imprinting disorders after ART.110 However, the study did find an increased risk of Beckwith-Wiedemann syndrome, with an aOR of 2.84 (95% CI 1.34–6.01). It is worth noting that findings were derived from a relatively small number of cases with Beckwith-Wiedemann syndrome within the ART cohort.110 The precise causes of imprinting disorders remain only partially understood, and their diverse clinical manifestations pose challenges in the clinical diagnosis.

Differences in global epigenetic patterns in children born after ART compared to NC children have been shown in some studies but should be interpreted with caution as no functional or health-related consequence later in life has been shown.111,112,113

Reproductive Health

In 2016, the first study was published examining semen quality in individuals conceived through ICSI.114 This study involved 54 young men, aged between 18 and 22 years, who were born between 1992 and 1996 as a result of ICSI due to severe male infertility. It was observed that, in comparison to men born through NC, the ICSI-conceived men exhibited significantly lower median sperm concentration, total sperm count, and total motile sperm count. These differences persisted even after adjusting for pertinent confounding factors.114 Current evidence does not indicate any significant alterations in the endocrine gonadal function of ICSI-conceived boys and young adults.115 Furthermore, in young women aged 18–22 years, who were conceived through ICSI due to male factor infertility (in total 71 individuals), the antral follicle count and circulating levels of reproductive hormones, including AMH (anti-Müllerian hormone), FSH (follicle stimulating hormone), LH (luteinizing hormone), and DHEAS (dehydroepiandrosterone), were found to be the same as in NC offspring.116

CONCLUSION

Knowledge of the short- and long-term health consequences of children born after ART procedures is vital for society, clinicians, and prospective parents. ART pregnancies carry unique risks compared to NC and the choice of ART procedure, such as ICSI versus IVF or FET versus fresh ET, requires careful consideration.

In light of the higher risks associated with ICSI, FET, programmed FET cycles, and blastocyst transfer, it is obvious that we should apply ART methods whenever they are needed to improve success rates, but we should never apply any add-on if it is not required. Hence ICSI should be performed by indication, and the same goes for FET and programmed FET. Regarding blastocyst transfer, the higher live birth rates by the longer in vitro culture and the selection procedure may outweigh the slightly higher risk after blastocyst transfer. Furthermore, new methods and culture media should be carefully registered to closely monitor the health of the offspring and to carefully plan treatment strategies according to the offspring’s health profiles of the treatments. All professionals in the field should bear in mind that the health of the offspring is the final goal of quality control in ART. With the declining birth rates and the increasing childbearing age worldwide, ART has become an important player in lifting the birth rates in society and will contribute to a significant proportion of future generations hence surveillance of their long-term health is crucial.

PRACTICE RECOMMENDATIONS

  • ART increases the risk of adverse perinatal outcomes such as preterm birth, low birth weight, and congenital malformations. The risks are particularly seen with multiple births. Hence, single embryo transfer is encouraged. However, a certain risk remains in ART singletons.
  • ICSI slightly increases the risk of major congenital malformations, and the indication should therefore be carefully considered.
  • Frozen embryo transfer (FET) increases the risk of hypertensive disorders of pregnancy (HDP), high birth weight and large for gestational age offspring compared to fresh embryo transfer. The risk of HDP is especially increased in programmed cycle FET, thus natural or stimulated FET cycles should be performed whenever possible.
  • ART with oocyte donation increases the risk of HDP compared to ART with autologous oocytes, hence single embryo transfer and prophylactic low-dose aspirin is recommended.
  • The risk of cerebral palsy has diminished with the single embryo transfer policy and is now similar in children born after ART compared to naturally conceived (NC) singletons.
  • Some studies indicate an increased risk of high blood pressure in children born after ART. While the overall risk of DM1 is similar in ART and NC, FET might increase the risk.
  • Studies on growth in ART children indicate that differences in anthropometrics at early childhood diminish over time. Studies on risk of obesity following ART are conflicting and long-term follow up studies are warranted.
  • The overall risk of cancer is not increased in children born after ART, but a slight increased risk is seen after FET. Imprinting disorders are more common in children born after ART compared to NC children. It is important to communicate this risk.
  • In general, single embryo transfer reduces adverse outcomes in ART children and should be preferred over double embryo transfer. Further, add-ons to the ART protocol should only be applied when necessary, as ICSI, FET and programmed FET seems to increase adverse outcomes.


CONFLICTS OF INTEREST

Professor Pinborg has received support from IBSA, Ferring Pharmaceuticals, Gedeon Richter, Cryos and Merck A/S and Organon.

GUIDELINES

FIGO: Good practice recommendations on reduction of preterm birth in pregnancies conceived by assisted reproductive technologies.117

ESHRE: Good practice recommendations on add-ons in reproductive medicine.118

REFERENCES

1

Pharoah POD. Risk of Cerebral Palsy in Multiple Pregnancies. Clin Perinatol 2006;33(2):301–13.

2

Lorenz JM. Neurodevelopmental Outcomes of Twins. Semin Perinatol 2012;36(3):201–12.

3

Hvidtjorn D, Grove J, Schendel D, et al. Multiplicity and early gestational age contribute to an increased risk of cerebral palsy from assisted conception: a population-based cohort study. Hum Reprod 2010;25(8):2115–23.

4

Goldsmith S, Mcintyre S, Badawi N, et al. Cerebral palsy after assisted reproductive technology: a cohort study. Developmental Medicine &amp Child Neurology 2017;60(1):73–80.

5

Berntsen S, Söderström-Anttila V, Wennerholm UB, et al. The health of children conceived by ART: ‘the chicken or the egg?’ Hum Reprod Update 2019;25(2):137–58.

6

Sazonova A, Källen K, Thurin-Kjellberg A, et al. Neonatal and maternal outcomes comparing women undergoing two in vitro fertilization (IVF) singleton pregnancies and women undergoing one IVF twin pregnancy. Fertil Steril 2013;99(3):731–7.

7

Pinborg A. IVF/ICSI twin pregnancies: risks and prevention. Hum Reprod Update 2005;11(6):575–93.

8

Spangmose AL, Christensen LH, Henningsen AKA, et al. Cerebral palsy in ART children has declined substantially over time: a Nordic study from the CoNARTaS group. Hum Reprod 2021;36(8):2358–70.

9

Thurin A, Hausken J, Hillensjö T, et al. Elective Single-Embryo Transfer versus Double-Embryo Transfer in in Vitro Fertilization. New England Journal of Medicine 2004;351(23):2392–402.

10

Ferraretti AP, Nygren K, Andersen AN, et al. Trends over 15 years in ART in Europe: an analysis of 6 million cycles. Hum Reprod Open 2017;2017(2):hox012–hox012.

11

Sunderam S, Kissin DM, Zhang Y, et al. Assisted Reproductive Technology Surveillance – United States, 2016. MMWR Surveillance Summaries 2019;68(4):1–23.

12

Gliozheni O, Hambartsoumian E, Strohmer H, et al. ART in Europe, 2016: results generated from European registries by ESHRE†. Hum Reprod Open 2020;2020(3).

13

de Mouzon J, Chambers GM, Zegers-Hochschild F, et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology 2012†. Hum Reprod 2020;35(8):1900–13.

14

Opdahl S, Henningsen AKA, Bergh C, et al. Data Resource Profile: Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS) cohort. Int J Epidemiol 2020;49(2):365–6f.

15

https://sundhedsdatastyrelsen.dk/-/media/sds/filer/find-tal-og-analyser/sygdomme-og-behandlinger/assisteret-reproduktion/assisteret-reproduktion-2019.pdf

16

Henningsen AA, Wennerholm UB, Gissler M, et al. Risk of stillbirth and infant deaths after assisted reproductive technology: a Nordic study from the CoNARTaS† group. Hum Reprod 2014;29(5):1090–6.

17

Bergh C, Wennerholm UB. Long-term health of children conceived after assisted reproductive technology. Ups J Med Sci 2020;125(2):152–7.

18

De Neubourg D, Dancet EAF, Pinborg A. Single-embryo transfer implies quality of care in reproductive medicine. Reprod Biomed Online 2022;45(5):899–905.

19

Qin JB, Sheng XQ, Wu D, et al. Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. Arch Gynecol Obstet 2017;295(2):285–301.

20

Wong K, Carson K, Crane J. Risk of stillbirth in singleton gestations following in vitro methods of conception: a systematic review and meta‐analysis. BJOG 2021;128(10):1563–72.

21

Zhao J, Yan Y, Huang X, et al. Do the children born after assisted reproductive technology have an increased risk of birth defects? A systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 2020;33(2):322–33.

22

Wang YP, Ray JG, Pudwell J, et al. Mode of conception and risk of spontaneous vs. provider-initiated preterm birth: population-based cohort study. Fertil Steril 2022;118(5):926–35.

23

Pinborg A, Wennerholm UB, Romundstad LB, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome ? Systematic review and meta-analysis. Hum Reprod Update 2013;19(2):87–104.

24

Sunkara SK, Antonisamy B, Redla AC, et al. Female causes of infertility are associated with higher risk of preterm birth and low birth weight: analysis of 117,401 singleton live births following IVF. Hum Reprod 2021;36(3):676–82.

25

Henningsen AKA, Opdahl S, Wennerholm UB, et al. Risk of congenital malformations in live-born singletons conceived after intracytoplasmic sperm injection: a Nordic study from the CoNARTaS group. Fertil Steril 2023;120(5).

26

Berntsen S, Laivuori H, la Cour Freiesleben N, et al. A systematic review and meta-analysis on the association between ICSI and chromosome abnormalities. Hum Reprod Update 2021;27(5):801–47.

27

Davies MJ, Moore VM, Willson KJ, et al. Reproductive Technologies and the Risk of Birth Defects. New England Journal of Medicine 2012;366(19):1803–13.

28

Davies M, Rumbold A, Marino J, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study. BJOG 2017;124(10):1537–44.

29

Wennerholm UB, Söderström-Anttila V, Bergh C, et al. Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data. Hum Reprod 2009;24(9):2158–72.

30

Maheshwari A, Pandey S, Shetty A, et al. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012;98(2):368–377.e9.

31

Zhao J, Xu B, Zhang Q, et al. Which one has a better obstetric and perinatal outcome in singleton pregnancy, IVF/ICSI or FET?: a systematic review and meta-analysis. Reprod Biol Endocrinol 2016;14(1):51.

32

Pelkonen S, Koivunen R, Gissler M, et al. Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006. Hum Reprod 2010;25(4):914–23.

33

Maheshwari A, Pandey S, Amalraj Raja E, et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update 2018;24(1):35–58.

34

Zaat T, Zagers M, Mol F, et al. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database of Systematic Reviews 2021;2021(2).

35

Ginström Ernstad E, Wennerholm UB, Khatibi A, et al. Neonatal and maternal outcome after frozen embryo transfer: Increased risks in programmed cycles. Am J Obstet Gynecol 2019;221(2):126.e1–18.

36

Asserhøj LL, Spangmose AL, Aaris Henningsen AK, et al. Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril 2021;115(4):947–56.

37

Busnelli A, Schirripa I, Fedele F, et al. Obstetric and perinatal outcomes following programmed compared to natural frozen-Thawed embryo transfer cycles: A systematic review and meta-Analysis. Hum Reprod 2022;37(7):1619–41.

38

Zaat TR, Kostova EB, Korsen P, et al. Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis. Hum Reprod Update 2023;29(5):634–54.

39

von Versen-Höynck F, Schaub AM, Chi YY, et al. Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum. Hypertension 2019;73(3):640–9.

40

von Versen-Höynck F, Strauch NK, Liu J, et al. Effect of Mode of Conception on Maternal Serum Relaxin, Creatinine, and Sodium Concentrations in an Infertile Population. Reprod Sci 2019;26(3):412–9.

41

von Versen-Höynck F, Narasimhan P, Selamet Tierney ES, et al. Absent or Excessive Corpus Luteum Number Is Associated With Altered Maternal Vascular Health in Early Pregnancy. Hypertension 2019;73(3):680–90.

42

Wale PL, Gardner DK. The effects of chemical and physical factors on mammalian embryo culture and their importance for the practice of assisted Hum Reprod. Hum Reprod Update 2016;22(1):2–22.

43

Dumoulin JC, Land JA, Van Montfoort AP, et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod 2010;25(3):605–12.

44

Kleijkers SHM, van Montfoort APA, Smits LJM, et al. IVF culture medium affects post-natal weight in humans during the first 2 years of life. Hum Reprod 2014;29(4):661–9.

45

Kleijkers SHM, Eijssen LMT, Coonen E, et al. Differences in gene expression profiles between human preimplantation embryos cultured in two different IVF culture media. Hum Reprod 2015;30(10):2303–11.

46

Hviid KVR, Malchau SS, Pinborg A, et al. Determinants of monozygotic twinning in ART: a systematic review and a meta-analysis. Hum Reprod Update 2018;24(4):468–83.

47

Chen D, Xu Q, Mao X, et al. Obstetric and perinatal outcomes after embryos cultured in one-step versus sequential culture media systems in vitrified–warmed single blastocyst transfer cycles. Reprod Biomed Online 2023;47(3):103227.

48

Marconi N, Allen CP, Bhattacharya S, et al. Obstetric and perinatal outcomes of singleton pregnancies after blastocyst-stage embryo transfer compared with those after cleavage-stage embryo transfer: A systematic review and cumulative meta-analysis. Hum Reprod Update2022;28(2):255–81.

49

Raja EA, Bhattacharya S, Maheshwari A, et al. A comparison of perinatal outcomes following fresh blastocyst or cleavage stage embryo transfer in singletons and twins and between singleton siblings. Hum Reprod Open 2023;2023(2).

50

Siristatidis C, Papapanou M, Karageorgiou V, et al. Congenital anomaly and perinatal outcome following blastocyst- vs. cleavage-stage embryo transfer: systematic review and network meta-analysis. Ultrasound in Obstetrics & Gynecology 2023;61(1):12–25.

51

Alfarawati S, Fragouli E, Colls P, et al. The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril 2011;95(2):520–4.

52

Tarín JJ, García-Pérez MA, Hermenegildo C, et al. Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles. Reprod Biol Endocrinol 2014;12(56):56.

53

Keukens A, Van Wely M, Van Der Meulen C, et al. Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: A systematic review and meta-analysis. Hum Reprod 2022;37(3):586–99.

54

Storgaard M, Loft A, Bergh C, et al. Obstetric and Neonatal Complications in Pregnancies Conceived after Oocyte Donation: A Systematic Review and Meta-Analysis. Obstetric Anesthesia Digest 2017;37(4):176–176.

55

Moreno – Sepulveda J, Checa MA. Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis. J Assist Reprod Genet2019;36(10):2017–37.

56

Kamath MS, Sunkara SK. Perinatal outcomes after oocyte donation and in-vitro fertilization. Curr Opin Obstet Gynecol2017;29(3):126–30.

57

Shenkin SD, Starr JM, Deary IJ. Birth Weight and Cognitive Ability in Childhood: A Systematic Review. Psychol Bull 2004;130(6):989–1013.

58

van Wassenaer A. Neurodevelopmental consequences of being born SGA. Pediatr Endocrinol Rev 2005;2(3):372–7.

59

Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment: Part I–General health outcomes. Hum Reprod Update 2013;19(3):232–43.

60

Bay B, Mortensen EL, Kesmodel US. Assisted reproduction and child neurodevelopmental outcomes: a systematic review. Fertil Steril 2013;100(3):844–53.

61

Djuwantono T, Aviani JK, Permadi W, et al. Risk of neurodevelopmental disorders in children born from different ART treatments: a systematic review and meta-analysis. J Neurodev Disord 2020;12(1):33.

62

Rumbold AR, Moore VM, Whitrow MJ, et al. The impact of specific fertility treatments on cognitive development in childhood and adolescence: a systematic review. Hum Reprod 2017;32(7):1489–507.

63

Spangmose AL, Malchau SS, Schmidt L, et al. Academic performance in adolescents born after ART – a nationwide registry-based cohort study. Hum Reprod 2017;32(2):447–56.

64

Norrman E, Petzold M, Bergh C, et al. School performance in singletons born after assisted reproductive technology. Hum Reprod 2018;33(10):1948–59.

65

Wienecke LS, Kjær SK, Frederiksen K, et al. Ninth-grade school achievement in Danish children conceived following fertility treatment: a population-based cohort study. Fertil Steril 2020;113(5):1014–23.

66

Norrman E, Petzold M, Bergh C, et al. School performance in children born after ICSI. Hum Reprod 2020;35(2):340–54.

67

Spangmose A, Malchau S, Henningsen A, et al. Academic performance in adolescents aged 15–16 years born after frozen embryo transfer compared with fresh embryo transfer: a nationwide registry‐based cohort study. BJOG 2019;126(2):261–9.

68

Pinborg A, Loft A, Schmidt L, et al. Neurological sequelae in twins born after assisted conception: controlled national cohort study. BMJ 2004;329(7461):311.

69

Maimburg RD, Vaeth M. Do children born after assisted conception have less risk of developing infantile autism? Hum Reprod 2007;22(7):1841–3.

70

Bay B, Mortensen EL, Hvidtjorn D, et al. Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study. BMJ 2013;347(jul05 1):f3978–f3978.

71

Rönö K, Rissanen E, Bergh C, et al. The neurodevelopmental morbidity of children born after assisted reproductive technology: a Nordic register study from the Committee of Nordic Assisted Reproductive Technology and Safety group. Fertil Steril 2022;117(5):1026–37.

72

Diop H, Cabral H, Gopal D, et al. Early Autism Spectrum Disorders in Children Born to Fertile, Subfertile, and ART-Treated Women. Matern Child Health J 2019;23(11):1489–99.

73

Svahn MF, Hargreave M, Nielsen TSS, et al. Mental disorders in childhood and young adulthood among children born to women with fertility problems. Hum Reprod 2015;30(9):2129–37.

74

Fine A, Dayan N, Djerboua M, et al. Attention-deficit hyperactivity disorder in children born to mothers with infertility: a population-based cohort study. Hum Reprod 2022;37(9):2126–34.

75

Källén AJB, Finnström OO, Lindam AP, et al. Is there an increased risk for drug treated attention deficit/hyperactivity disorder in children born after in vitro fertilization? European Journal of Paediatric Neurology 2011;15(3):247–53.

76

Graham HK, Rosenbaum P, Paneth N, et al. Cerebral palsy. Nat Rev Dis Primers 2016;2(1):15082.

77

Strömberg B, Dahlquist G, Ericson A, et al. Neurological sequelae in children born after in-vitro fertilisation: a population-based study. The Lancet 2002;359(9305):461–5.

78

Hvidtjørn D, Grove J, Schendel DE, et al. Cerebral Palsy Among Children Born After in Vitro Fertilization: The Role of Preterm Delivery – A Population-Based, Cohort Study. Pediatrics 2006;118(2):475–82.

79

Klemetti R, Sevón T, Gissler M, et al. Health of Children Born as a Result of In Vitro Fertilization. Pediatrics 2006;118(5):1819–27.

80

Källén AJB, Finnström OO, Lindam AP, et al. Cerebral palsy in children born after in vitro fertilization. Is the risk decreasing? European Journal of Paediatric Neurology 2010;14(6):526–30.

81

Goldsmith S, Mcintyre S, Badawi N, et al. Cerebral palsy after assisted reproductive technology: a cohort study. Dev Med Child Neurol 2018;60(1):73–80.

82

Reid SM, Jaques AM, Susanto C, et al. Cerebral palsy and assisted reproductive technologies: a case–control study. Dev Med Child Neurol 2010;52(7).

83

Carlsen H, Vik T, Andersen GL, et al. Cerebral palsy in children born after assisted reproductive technology in Norway: Risk, prevalence, and clinical characteristics. Acta Obstet Gynecol Scand 2023;102(11):1450–8.

84

Ceelen M, van Weissenbruch MM, Vermeiden JPW, et al. Cardiometabolic Differences in Children Born After in Vitro Fertilization: Follow-Up Study. The Journal of Clinical Endocrinology & Metabolism 2008;93(5):1682–8.

85

Ceelen M, van Weissenbruch MM, Prein J, et al. Growth during infancy and early childhood in relation to blood pressure and body fat measures at age 8–18 years of IVF children and spontaneously conceived controls born to subfertile parents. Hum Reprod 2009;24(11):2788–95.

86

Meister TA, Rimoldi SF, Soria R, et al. Association of Assisted Reproductive Technologies With Arterial Hypertension During Adolescence. J Am Coll Cardiol 2018;72(11):1267–74.

87

Zhou J, Liu H, Gu H tao, et al. Association of Cardiac Development with Assisted Reproductive Technology in Childhood: A Prospective Single-Blind Pilot Study. Cellular Physiology and Biochemistry 2014;34(3):988–1000.

88

Liu H, Zhang Y, Gu HT, et al. Association Between Assisted Reproductive Technology and Cardiac Alteration at Age 5 Years. JAMA Pediatr 2015;169(6):603.

89

Hart R, Norman RJ. The longer-term health outcomes for children born as a result of IVF treatment: Part I–General health outcomes. Hum Reprod Update 2013;19(3):232–43.

90

Guo XY, Liu XM, Jin L, et al. Cardiovascular and metabolic profiles of offspring conceived by assisted reproductive technologies: a systematic review and meta-analysis. Fertil Steril 2017;107(3):622–631.e5.

91

Mizrak I, Asserhøj LL, Lund MAV, et al. Cardiovascular function in 8- to 9-year-old singletons born after ART with frozen and fresh embryo transfer. Hum Reprod 2022;37(3):600–11.

92

Sciuk F, Vilsmaier T, Kramer M, et al. Left ventricular systolic function in subjects conceived through assisted reproductive technologies. Front Cardiovasc Med 2023;10.

93

Wijs LA, Doherty DA, Keelan JA, et al. Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort. Hum Reprod 2022;37(8):1880–95.

94

Norrman E, Petzold M, Gissler M, et al. Cardiovascular disease, obesity, and type 2 diabetes in children born after assisted reproductive technology: A population-based cohort study. PLoS Med 2021;18(9):e1003723.

95

Hargreave M, Kjaer SK, Jørgensen ME, et al. Type 1 diabetes risk in children born to women with fertility problems: a cohort study in 1.5 million Danish children. Acta Obstet Gynecol Scand 2016;95(12):1441–6.

96

Kettner LO, Matthiesen NB, Ramlau-Hansen CH, et al. Fertility treatment and childhood type 1 diabetes mellitus: a nationwide cohort study of 565,116 live births. Fertil Steril 2016;106(7):1751–6.

97

Norrman E, Petzold M, Clausen TD, et al. Type 1 diabetes in children born after assisted reproductive technology: a register-based national cohort study. Hum Reprod 2020;35(1):221–31.

98

Zhang Y, Liu P, Zhou W, et al. Association of large for gestational age with cardiovascular metabolic risks: a systematic review and meta‐analysis. Obesity 2023;31(5):1255–69.

99

Kyhl F, Spangsmose AL, Gissler M, et al. P-767 The risk of type 1 diabetes in ART children – a Nordic cohort study on 4,589,587 liveborn children. Hum Reprod 2022;37(Supplement_1).

100

Bay B, Lyngsø J, Hohwü L, et al. Childhood growth of singletons conceived following in vitro fertilisation or intracytoplasmic sperm injection: a systematic review and meta-analysis. BJOG2019;126(2):158–66.

101

Elhakeem A, Taylor AE, Inskip HM, et al. Association of Assisted Reproductive Technology With Offspring Growth and Adiposity From Infancy to Early Adulthood. JAMA Netw Open 2022;5(7):E2222106.

102

Asserhøj LL, Mizrak I, Heldarskard GF, et al. Childhood BMI after ART with frozen embryo transfer. Hum Reprod 2023;38(8):1578–89.

103

Zhang Y, Gao R, Chen H, et al. The association between fertility treatments and the incidence of paediatric cancer: A systematic review and meta-analysis. Eur J Cancer 2020;138:133–48.

104

Gilboa D, Koren G, Barer Y, et al. Assisted reproductive technology and the risk of pediatric cancer: A population based study and a systematic review and meta analysis. Cancer Epidemiol 2019;63:101613.

105

Hargreave M, Jensen A, Hansen MK, et al. Association Between Fertility Treatment and Cancer Risk in Children. JAMA 2019;322(22):2203.

106

Sargisian N, Lannering B, Petzold M, et al. Cancer in children born after frozen-thawed embryo transfer: A cohort study. PLoS Med 2022;19(9):e1004078.

107

Magnusson Å, Laivuori H, Loft A, et al. The Association Between High Birth Weight and Long-Term Outcomes – Implications for Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis. Front Pediatr 2021;9(June).

108

Soellner L, Begemann M, Mackay DJG, et al. Recent Advances in Imprinting Disorders. Clin Genet 2016;91(1):3–13.

109

Cortessis VK, Azadian M, Buxbaum J, et al. Comprehensive meta-analysis reveals association between multiple imprinting disorders and conception by assisted reproductive technology. J Assist Reprod Genet 2018;35(6):943–52.

110

Henningsen AA, Gissler M, Rasmussen S, et al. Imprinting disorders in children born after ART: a Nordic study from the CoNARTaS group. Hum Reprod 2020;35(5):1178–84.

111

Håberg SE, Page CM, Lee Y, et al. DNA methylation in newborns conceived by assisted reproductive technology. Nat Commun 2022;13(1):1896.

112

Barberet J, Ducreux B, Guilleman M, et al. DNA methylation profiles after ART during human lifespan: a systematic review and meta-analysis. Hum Reprod Update 2022;28(5):629–55.

113

Novakovic B, Lewis S, Halliday J, et al. Assisted reproductive technologies are associated with limited epigenetic variation at birth that largely resolves by adulthood. Nat Commun 2019;10(1):3922.

114

Belva F, Bonduelle M, Roelants M, et al. Semen quality of young adult ICSI offspring: the first results. Hum Reprod 2016;31(12):2811–20.

115

Belva F, Bonduelle M, Tournaye H. Endocrine and reproductive profile of boys and young adults conceived after ICSI. Curr Opin Obstet Gynecol 2019;31(3):163–9.

116

Belva F, Roelants M, Vloeberghs V, et al. Serum reproductive hormone levels and ultrasound findings in female offspring after intracytoplasmic sperm injection: first results. Fertil Steril 2017;107(4):934–9.

117

Mol BW, Jacobsson B, Grobman WA, et al. FIGO good practice recommendations on reduction of preterm birth in pregnancies conceived by assisted reproductive technologies. International Journal of Gynecology & Obstetrics 2021;155(1):13–5.

118

Lundin K, Bentzen JG, Bozdag G, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod 2023.

Online Study Assessment Option
All readers who are qualified doctors or allied medical professionals can now automatically receive 2 Continuing Professional Development credits from FIGO plus a Study Completion Certificate from GLOWM for successfully answering 4 multiple choice questions (randomly selected) based on the study of this chapter.
Medical students can receive the Study Completion Certificate only.

 

(To find out more about FIGO’s Continuing Professional Development awards programme CLICK HERE)